Characterization of inflammation and fibrosis in Crohn's disease lesions by magnetic resonance imaging
- PMID: 25623654
- DOI: 10.1038/ajg.2014.424
Characterization of inflammation and fibrosis in Crohn's disease lesions by magnetic resonance imaging
Erratum in
-
Corrigendum: Characterization of inflammation and fibrosis in Crohn's disease lesions by magnetic resonance imaging.Am J Gastroenterol. 2015 Mar;110(3):480. doi: 10.1038/ajg.2015.40. Am J Gastroenterol. 2015. PMID: 25743724 No abstract available.
Abstract
Objectives: Measurement of the component of fibrosis in Crohn's disease (CD) may have important therapeutic implications. The aim of this study was to characterize the Magnetic Resonance Imaging (MRI) findings that are differentially associated with the presence of fibrosis and those associated with inflammatory activity, using the pathological analysis of surgically resected intestinal lesions as reference standard.
Methods: MRI studies with identical imaging protocol of 41 CD patients who underwent elective bowel resection within 4 months before surgery were reviewed. MRI evaluated wall thickening, edema, ulcers, signal intensity at submucosa at 70 s and 7 min after gadolinium injection, stenosis, and pattern of enhancement in each phase of the dynamic study and changes on this pattern over time. Pathological inflammatory and fibrosis scores were classified into three grades of severity.
Results: In all, 44 segments from 41 patients were analyzed. The pathological intensity of inflammation was associated with the following MRI parameters: hypersignal on T2 (P=0.02), mucosal enhancement (P=0.03), ulcerations (P=0.01), and blurred margins (P=0.05). The degree of fibrosis correlated with the percentage of enhancement gain (P<0.01), the pattern of enhancement at 7 min (P<0.01), and the presence of stenosis (P=0.05). Using percentage of enhancement gain, MRI is able to discriminate between mild-moderate and severe fibrosis deposition with a sensitivity of 0.94 and a specificity of 0.89.
Conclusions: MRI is accurate for detecting the presence of severe fibrosis in CD lesions on the basis of the enhancement pattern.
Comment in
-
Characterization of inflammation and fibrosis in Crohn's disease lesions by magnetic resonance imaging.Am J Gastroenterol. 2015 Mar;110(3):441-3. doi: 10.1038/ajg.2015.26. Am J Gastroenterol. 2015. PMID: 25743712 No abstract available.
Similar articles
-
Which magnetic resonance imaging findings accurately evaluate inflammation in small bowel Crohn's disease? A retrospective comparison with surgical pathologic analysis.Inflamm Bowel Dis. 2011 Apr;17(4):984-93. doi: 10.1002/ibd.21414. Epub 2010 Aug 18. Inflamm Bowel Dis. 2011. PMID: 20722053
-
Use of magnetic resonance index of activity (MaRIA) in the preoperative assessment of small bowel Crohn's disease.Cir Esp (Engl Ed). 2019 Dec;97(10):582-589. doi: 10.1016/j.ciresp.2019.06.018. Epub 2019 Oct 2. Cir Esp (Engl Ed). 2019. PMID: 31585676 English, Spanish.
-
Magnetisation transfer imaging adds information to conventional MRIs to differentiate inflammatory from fibrotic components of small intestinal strictures in Crohn's disease.Eur Radiol. 2020 Apr;30(4):1938-1947. doi: 10.1007/s00330-019-06594-x. Epub 2020 Jan 3. Eur Radiol. 2020. PMID: 31900705 Free PMC article.
-
Value of T2-weighted magnetic resonance imaging in the assessment of wall inflammation and fibrosis in Crohn's disease.Abdom Imaging. 2012 Dec;37(6):944-57. doi: 10.1007/s00261-012-9853-y. Abdom Imaging. 2012. PMID: 22639331 Review.
-
Assessment of wall inflammation and fibrosis in Crohn's disease: value of T1-weighted gadolinium-enhanced MR imaging.Abdom Imaging. 2012 Dec;37(6):933-43. doi: 10.1007/s00261-011-9821-y. Abdom Imaging. 2012. PMID: 22113650 Review.
Cited by
-
Crohn's Disease: Radiological Answers to Clinical Questions and Review of the Literature.J Clin Med. 2024 Jul 16;13(14):4145. doi: 10.3390/jcm13144145. J Clin Med. 2024. PMID: 39064186 Free PMC article. Review.
-
Novel biomarkers of fibrosis in Crohn's disease.World J Gastrointest Pathophysiol. 2016 Aug 15;7(3):266-75. doi: 10.4291/wjgp.v7.i3.266. World J Gastrointest Pathophysiol. 2016. PMID: 27574564 Free PMC article. Review.
-
Comparative analysis of [18F]F-FAPI PET/CT, [18F]F-FDG PET/CT and magnetization transfer MR imaging to detect intestinal fibrosis in Crohn's disease: A prospective animal model and human cohort study.Eur J Nucl Med Mol Imaging. 2024 Jun;51(7):1856-1868. doi: 10.1007/s00259-024-06644-7. Epub 2024 Feb 15. Eur J Nucl Med Mol Imaging. 2024. PMID: 38355741
-
A novel collagen area fraction index to quantitatively assess bowel fibrosis in patients with Crohn's disease.BMC Gastroenterol. 2019 Nov 11;19(1):180. doi: 10.1186/s12876-019-1100-3. BMC Gastroenterol. 2019. PMID: 31711420 Free PMC article.
-
Intestinal fibrosis classification in patients with Crohn's disease using CT enterography-based deep learning: comparisons with radiomics and radiologists.Eur Radiol. 2022 Dec;32(12):8692-8705. doi: 10.1007/s00330-022-08842-z. Epub 2022 May 26. Eur Radiol. 2022. PMID: 35616733
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical